Decision support systems for morphology-based diagnosis and prognosis of prostate neoplasms: A methodological approach

Cancer

Volumn 115, Issue SUPPL 13, 2009, Pages 3068-3077

  Montironi, Rodolfo ^a   Cheng, Liang ^b   Lopez Beltran, Antonio ^c   Mazzucchelli, Roberta ^a   Scarpelli, Marina ^a   Bartels, Peter H ^d  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b INDIANA UNIVERSITY   (United States)

^c UNIVERSITY OF CÓRDOBA   (Spain)

^d UNIVERSITY OF ARIZONA   (United States)

Author keywords

Automated reasoning systems; Case based reasoning systems; Diagnostic decision support systems; Inference networks; Prostate cancer

Indexed keywords

CONFERENCE PAPER; DECISION SUPPORT SYSTEM; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; INFORMATION TECHNOLOGY; LINGUISTICS; MALE; MORPHOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROSTATE ADENOCARCINOMA; PROSTATE CANCER;

ADENOCARCINOMA; DECISION SUPPORT SYSTEMS, CLINICAL; HUMANS; MALE; PROGNOSIS; PROSTATIC NEOPLASMS;

EID: 67649960426     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24345     Document Type: Conference Paper

References (43)

1. Bostwick DG. Practical clinical application of predictive factors in prostate cancer. A review with an emphasis on quantitative methods in tissue specimens. Anal Quant Cytol Histol. 1998;20:323-342.
2. Ranger-Moore J, Alberts DS, Montironi R, et al. Karyometry in the early detection and chemoprevention of intraepithelial lesions. Eur J Cancer. 2005;41:1875-1888.
3. Bartels PH, Thompson D, Montironi R, Mariuzzi G, Hamilton PW. Automated reasoning system in histopathologic diagnosis and prognosis of prostate cancer and its precursors. Eur Urol. 1996;30:222-233.
4. Makarov DV, Marlow C, Epstein JI, et al. Using nuclear morphometry to predict the need for treatment among men with low grade, low stage prostate cancer enrolled in a program of expectant management with curative intent. Prostate. 2008;68:183-189.
5. Veltri RW, Miller MC, Isharwal S, Marlow C, Makarov DV, Partin AW. Prediction of prostate-specific antigen recurrence in men with long-term follow-up post-prostatectomy using quantitative nuclear morphometry. Cancer Epidemiol Biomarkers Prev. 2008;17:102-110.
6. Kelloff GJ, Sullivan DC, Baker H, et al. Workshop Program Committee. Workshop on imaging science development for cancer prevention and preemption. Cancer Biomark. 2007;3:1-33.
7. Montironi R, Mazzucchelli R, Marshall J, Bartels PH. Prostate cancer chemoprevention. J Clin Pathol. 1999;52:793-803.
8. Montironi R, Mazzucchelli R, Bostwick DG, et al. Recent advances in the quantitative morphological evaluation of prostate cancer. J Urol Pathol. 2000;12:133-168.
9. Abbod MF, Catto JW, Linkens DA, Hamdy FC. Application of artificial intelligence to the management of urological cancer. J Urol. 2007;178:1150-1156.
10. Price GJ, McCluggage WG, Morrison MML, et al. Computerized diagnostic decision support system for the classification of preinvasive cervical squamous lesions. Hum Pathol. 2003;34:1193-1203.
11. Bartels PH, Thompson D, Montironi R, Hamilton PW, Scarpelli M. Diagnostic decision support for prostate lesions. Pathol Res Pract. 1995;191:945-957.
12. Morrison ML, McCluggage WG, Price GJ, et al. Expert system support using a Bayesian belief network for the classification of endometrial hyperplasia. J Pathol. 2002;197:403-414.
13. Hamilton PW, Montironi R, Abmayr W, et al. Clinical applications of Bayesian belief networks in pathology. Pathologica. 1995;87:237-245.
14. Neapolitan RE. Probabilistic Reasoning in Expert Systems. New York, NY: John Wiley & Sons; 1990.
15. Mazzucchelli R, Santinelli A, Colanzi P, et al. Urothelial papillary lesions. Development of a Bayesian belief network for diagnosis and grading. Anticancer Res. 2001;21:1157-1162.
16. Montironi R, Mazzucchelli R, Colanzi P, et al. Improving inter-observer agreement and certainty level in diagnosing and grading papillary urothelial neoplasms: usefulness of a Bayesian belief network. Eur Urol. 2002;41:449-457.
17. Montironi R, Mazzucchelli R, Santinelli A, Hamilton PW, Thompson D, Bartels PH. Case diagnosis as positive identification in prostatic neoplasia. Anal Quant Cytol Histol. 1998;20:424-436.
18. Montironi R, Bartels PH, Hamilton PW, Thompson D. Atypical adenomatous hyperplasia (adenosis) of the prostate: development of a Bayesian belief network for its distinction from well-differentiated adenocarcinoma. Hum Pathol. 1996;27:396-407.
19. Montironi R, Bartels PH, Thompson D, Diamanti L, Prete E. Androgen-deprived prostate adenocarcinoma: evaluation of treatment-related changes versus no distinctive treatment effect with a Bayesian belief network. A methodological approach. Eur Urol. 1996;30:307-315.
20. Montironi R, Bartels PH, Thomson D, Scarpelli M, Hamilton PW. Prostatic intraepithelial neoplasia: performance of a Bayesian belief network for diagnosis and grading. J Pathol. 1995;177:153-162.
21. Montironi R, Pomante R, Diamanti L, Hamilton PW, Thompson D, Bartels PH. Evaluation of prostatic intraepithelial neoplasia after treatment with a 5-alpha-reductase inhibitor (finasteride). A methodologic approach. Anal Quant Cytol Histol. 1996;18:461-470.
22. Montironi R, Santinelli A, Pomante R, Hamilton PW, Thompson D, Bartels PH. Inference network-based analyses of the histopathological effects of androgen deprivation on prostate cancer. J Pathol. 1999;187:462-468.
23. Montironi R, Ball RY, Griffiths DF, et al. Bayesian belief network for the Gleason patterns in prostatic adenocarcinoma: development of a diagnostic decision support system for educational purposes. Anal Quant Cytol Histol. 2008;30:8-15.
24. Gleason DF. Classification of prostatic carcinomas. Cancer Chemother Rep. 1966;50:125-128.
25. Helpap B, Egevad L. Correlation of modified Gleason grading with pT stage of prostatic carcinoma after radical prostatectomy. Anal Quant Cytol Histol. 2008;30:1-7.
26. Mazzucchelli R, Barbisan F, Tarquini LM, Filosa A, Campanini N, Galosi AB. Gleason grading of prostate carcinoma in needle biopsies vs. radical prostatectomy specimens. Anal Quant Cytol Histol. 2005;27:125-133.
27. Griffiths DF, Melia J, McWilliam LJ, et al. A study of Gleason score interpretation in different groups of UK pathologists; techniques for improving reproducibility. Histopathology. 2006;48:655-662.
28. Lopez-Beltran A, Mikuz G, Luque RJ, Mazzucchelli R, Montironi R. Current practice of Gleason grading of prostate carcinoma. Virchows Arch. 2006;448:111-118.
29. Melia J, Moseley R, Ball RY, et al. A UK-based investigation of inter- and intra-observer reproducibility of Gleason grading of prostatic biopsies. Histopathology. 2006;48:644-654.
30. Diamanti L, Montironi R, Prete E. Up-date on quantitative grading systems and prognosis. Anticancer Res. 1994;14:1297-1304.
31. Veltri RW, Marlow C, Khan MA, Miller MC, Epstein JI, Partin AW. Significant variations in nuclear structure occur between and within Gleason grading patterns 3, 4, and 5 determined by digital image analysis. Prostate. 2007;67:1202-1210.
32. Montironi R, Whimster WF, Collan Y, Hamilton PW, Thompson D, Bartels PH. How to develop and use a Bayesian belief network, illustrated with an example. J Clin Pathol. 1996;49:194-201.
33. Bartels PH, Thompson D, Weber JE. Diagnostic and prognostic decision support systems. Pathologica. 1995;87:115-130.
34. Bichindaritz I. Memoire: a framework for semantic interoperability of case-based reasoning systems in biology and medicine. Artif Intell Med. 2006;36:177-192.
35. Bichindaritz I, Marling C. Case-based reasoning in the health sciences: what's next? Artif Intell Med. 2006;36:127-135.
36. Gortler J, Berghoff M, Kayser G, Kayser K. Grid technology in tissue-based diagnosis: fundamentals and potential developments. Diagn Pathol. 2006;1:23.
37. Kayser K, Gortler J, Goldmann T, Vollmer E, Hufnagl P, Kayser G. Image standards in tissue-based diagnosis (diagnostic surgical pathology). Diagn Pathol 2008;18:3:17.
38. Kayser K, Hoshang SA, Metze K, et al. Texture-and object-related automated information analysis in histological still image of various organs. Anal Quant Cytol Histol. 2008;30:323-335.
39. Pantazi SV, Arocha JF, Moehr JR. Case-based medical informatics. BMC Med Inform Decis Mak. 2004;4:19.
40. Schmidt R, Vorobieva O. Case-based reasoning to explain medical model exceptions. Stud Health Technol Inform. 2008;136:259-264.
41. Hamilton PW, Bartels PH, Anderson NH, Thompson D, Montironi R, Sloan JM. Patient-based prediction of survival in colorectal cancer patients. Anal Quant Cytol Histol. 1999;21:283-291.
42. Mariuzzi GM, Bartels PH, Hamilton PW, Thompson D. Patient targeted prognosis: an exploration of case-based reasoning. Proceedings of the 5th National Congress of the Italian Society of Pathology, Abano Terme, Padova, Italy, 1995.
43. Kolodner J. Case-based Reasoning. San Mateo, CA: Morgan Kaufmann; 1993.